US equities |
SPCX $168.87 ▲+6.23% NVDA $237.91 ▲+1.69% MU $1,065.23 ▼-0.90% TSLA $380.33 ▲+2.63% MSFT $525.27 ▲+1.50% SNDK $1,716.09 ▼-0.23% INTC $117.08 ▼-1.89% META $745.24 ▲+2.36%
FinancialContent

GH Research PLC - Ordinary Shares (NQ:GHRS)

22.27 -0.67 (-2.92%)
Delayed Quote Updated: 1:44 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GH Research PLC - Ordinary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023 ↗
 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023 ↗
 
Via Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products ↗
Two psychedelics companies have shared their updates and key milestones to be reached this 2023. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 9, 2023 ↗
 
Via Benzinga
News headline image
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
From GH Research PLC
Via GlobeNewswire
News headline image
My "Rags-To-Riches" Portfolio For 2023: An Introduction ↗
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up? 
Via Talk Markets
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 3, 2023 ↗
 
Via Benzinga
News headline image
6 Largest Psychedelic Drug Stocks Were -20% In December ↗
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to... 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From December 30, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 29, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 28, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 27, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 26, 2022 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 23, 2022 ↗
 
Via Benzinga
Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month ↗
Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 21, 2022 ↗
 
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 19, 2022 ↗
 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >